Nancy Reau, MD: Obeticholic Acid’s Future in PBC After FDA Advisory Committee Meeting
HCPLive
SEPTEMBER 20, 2024
Reau explains the importance of second- and third-line treatment in PBC and the potential implications of no longer having OCA after a negative FDA advisory committee meeting.
Let's personalize your content